Positives

• A patient noted the combo broadens coverage versus rifaximin alone, especially for methane and mixed H2/H2S patterns where rifaximin monotherapy underperforms Dr. Oracle.
  
  
• A patient reported clinical improvement in bloating and constipation with the 10-14 day dual protocol SIBOInfo.
  
  

Negatives

• A patient described oral thrush, persistent vaginal irritation and microbiome disruption from the metronidazole component PMC.
  
  
• A patient cited disulfiram-like reaction with even small alcohol exposures, plus metallic taste throughout treatment PubMed.
  
  

Hurdles & Side Effects

• A patient noted the rifaximin component remained expensive and frequently denied by insurance, even with combination justification VA Formulary.
  
  
• A patient noted true H2S SIBO actually requires bismuth or trimethoprim/sulfamethoxazole rather than this combo, leaving them mis-treated initially SIBOInfo.